Medical - Instruments & Supplies
Compare Stocks
5 / 10Stock Comparison
MBOT vs SSYS vs DDD vs NNDM vs XMTR
Revenue, margins, valuation, and 5-year total return — side by side.
Computer Hardware
Computer Hardware
Computer Hardware
Industrial - Machinery
MBOT vs SSYS vs DDD vs NNDM vs XMTR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Medical - Instruments & Supplies | Computer Hardware | Computer Hardware | Computer Hardware | Industrial - Machinery |
| Market Cap | $143M | $707M | $350M | $389M | $3.95B |
| Revenue (TTM) | $0.00 | $551M | $387M | $118M | $741M |
| Net Income (TTM) | $-13M | $-104M | $64M | $-338M | $-52M |
| Gross Margin | — | 43.6% | 33.9% | 34.4% | 39.3% |
| Operating Margin | — | -11.7% | -24.8% | -61.8% | -4.8% |
| Forward P/E | — | 69.8x | 12.6x | 185.0x | 117.0x |
| Total Debt | $111K | $27M | $61M | $9M | $349M |
| Cash & Equiv. | $3M | $95M | $96M | $205M | $15M |
MBOT vs SSYS vs DDD vs NNDM vs XMTR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 21 | May 26 | Return |
|---|---|---|---|
| Microbot Medical In… (MBOT) | 100 | 26.8 | -73.2% |
| Stratasys Ltd. (SSYS) | 100 | 31.7 | -68.3% |
| 3D Systems Corporat… (DDD) | 100 | 6.0 | -94.0% |
| Nano Dimension Ltd. (NNDM) | 100 | 22.5 | -77.5% |
| Xometry, Inc. (XMTR) | 100 | 89.8 | -10.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: MBOT vs SSYS vs DDD vs NNDM vs XMTR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
MBOT lags the leaders in this set but could rank higher in a more targeted comparison.
Among these 5 stocks, SSYS doesn't own a clear edge in any measured category.
DDD carries the broadest edge in this set and is the clearest fit for value and quality.
- Lower P/E (12.6x vs 117.0x)
- 16.7% margin vs NNDM's -286.7%
- 11.5% ROA vs NNDM's -48.4%, ROIC -28.8% vs -15.2%
NNDM is the #2 pick in this set and the best alternative if growth exposure and sleep-well-at-night is your priority.
- Rev growth 77.3%, EPS growth -211.4%, 3Y rev CAGR 32.9%
- Lower volatility, beta 1.74, Low D/E 1.7%, current ratio 10.02x
- Beta 1.74, current ratio 10.02x
- 77.3% revenue growth vs MBOT's -17.1%
XMTR ranks third and is worth considering specifically for income & stability and long-term compounding.
- Dividend streak 1 yrs, beta 1.94
- -10.2% 10Y total return vs SSYS's -60.6%
- +162.1% vs SSYS's -15.6%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 77.3% revenue growth vs MBOT's -17.1% | |
| Value | Lower P/E (12.6x vs 117.0x) | |
| Quality / Margins | 16.7% margin vs NNDM's -286.7% | |
| Stability / Safety | Beta 1.74 vs DDD's 3.12, lower leverage | |
| Dividends | Tie | None of these 5 stocks pay a meaningful dividend |
| Momentum (1Y) | +162.1% vs SSYS's -15.6% | |
| Efficiency (ROA) | 11.5% ROA vs NNDM's -48.4%, ROIC -28.8% vs -15.2% |
MBOT vs SSYS vs DDD vs NNDM vs XMTR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
MBOT vs SSYS vs DDD vs NNDM vs XMTR — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
XMTR leads in 2 of 6 categories
DDD leads 1 • MBOT leads 0 • SSYS leads 0 • NNDM leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — SSYS and DDD each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
XMTR and MBOT operate at a comparable scale, with $741M and $0 in trailing revenue. DDD is the more profitable business, keeping 16.7% of every revenue dollar as net income compared to NNDM's -2.9%. On growth, NNDM holds the edge at +106.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $0 | $551M | $387M | $118M | $741M |
| EBITDAEarnings before interest/tax | -$14M | -$32M | -$78M | -$54M | -$21M |
| Net IncomeAfter-tax profit | -$13M | -$104M | $64M | -$338M | -$52M |
| Free Cash FlowCash after capex | -$11M | -$8M | -$98M | -$105M | -$11M |
| Gross MarginGross profit ÷ Revenue | — | +43.6% | +33.9% | +34.4% | +39.3% |
| Operating MarginEBIT ÷ Revenue | — | -11.7% | -24.8% | -61.8% | -4.8% |
| Net MarginNet income ÷ Revenue | — | -18.9% | +16.7% | -2.9% | -7.0% |
| FCF MarginFCF ÷ Revenue | — | -1.4% | -25.3% | -89.2% | -1.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | -6.9% | -4.3% | +106.4% | +35.9% |
| EPS Growth (YoY)Latest quarter vs prior year | +62.8% | +62.7% | +116.0% | +100.0% | +66.7% |
Valuation Metrics
Evenly matched — SSYS and DDD and NNDM and XMTR each lead in 1 of 4 comparable metrics.
Valuation Metrics
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $143M | $707M | $350M | $389M | $4.0B |
| Enterprise ValueMkt cap + debt − cash | $140M | $639M | $315M | $194M | $4.3B |
| Trailing P/EPrice ÷ TTM EPS | -2.92x | -6.41x | 12.61x | -1.35x | -64.34x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 69.79x | — | 185.00x | 116.97x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | — | — | — | — |
| Price / SalesMarket cap ÷ Revenue | — | 1.28x | 0.90x | 3.80x | 5.76x |
| Price / BookPrice ÷ Book value/share | 9.44x | 0.79x | 1.73x | 0.72x | 14.41x |
| Price / FCFMarket cap ÷ FCF | — | — | — | — | — |
Profitability & Efficiency
DDD leads this category, winning 3 of 9 comparable metrics.
Profitability & Efficiency
DDD delivers a 30.1% return on equity — every $100 of shareholder capital generates $30 in annual profit, vs $-59 for NNDM. NNDM carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to XMTR's 1.26x. On the Piotroski fundamental quality scale (0–9), SSYS scores 6/9 vs NNDM's 2/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -37.1% | -12.3% | +30.1% | -58.7% | -18.8% |
| ROA (TTM)Return on assets | -34.4% | -9.6% | +11.5% | -48.4% | -7.3% |
| ROICReturn on invested capital | -6.2% | -5.8% | -28.8% | -15.2% | -5.7% |
| ROCEReturn on capital employed | -2.9% | -6.6% | -22.1% | -12.6% | -7.5% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 6 | 4 | 2 | 3 |
| Debt / EquityFinancial leverage | 0.03x | 0.03x | 0.25x | 0.02x | 1.26x |
| Net DebtTotal debt minus cash | -$3M | -$68M | -$35M | -$195M | $334M |
| Cash & Equiv.Liquid assets | $3M | $95M | $96M | $205M | $15M |
| Total DebtShort + long-term debt | $111,000 | $27M | $61M | $9M | $349M |
| Interest CoverageEBIT ÷ Interest expense | — | — | 51.44x | -45.71x | -20.58x |
Total Returns (Dividends Reinvested)
XMTR leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in XMTR five years ago would be worth $8,983 today (with dividends reinvested), compared to $1,247 for DDD. Over the past 12 months, XMTR leads with a +162.1% total return vs SSYS's -15.6%. The 3-year compound annual growth rate (CAGR) favors XMTR at 81.1% vs DDD's -35.9% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +0.9% | -9.0% | +29.5% | +18.6% | +25.1% |
| 1-Year ReturnPast 12 months | -15.1% | -15.6% | +22.2% | +16.4% | +162.1% |
| 3-Year ReturnCumulative with dividends | +85.2% | -42.9% | -73.7% | -30.2% | +493.8% |
| 5-Year ReturnCumulative with dividends | -69.7% | -59.1% | -87.5% | -72.3% | -10.2% |
| 10-Year ReturnCumulative with dividends | -99.4% | -60.6% | -81.1% | -97.5% | -10.2% |
| CAGR (3Y)Annualised 3-year return | +22.8% | -17.0% | -35.9% | -11.3% | +81.1% |
Risk & Volatility
Evenly matched — NNDM and XMTR each lead in 1 of 2 comparable metrics.
Risk & Volatility
NNDM is the less volatile stock with a 1.74 beta — it tends to amplify market swings less than DDD's 3.12 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. XMTR currently trades 95.6% from its 52-week high vs MBOT's 45.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.85x | 1.79x | 3.12x | 1.74x | 1.94x |
| 52-Week HighHighest price in past year | $4.67 | $12.81 | $3.80 | $2.32 | $82.11 |
| 52-Week LowLowest price in past year | $1.60 | $7.34 | $1.32 | $1.31 | $29.60 |
| % of 52W HighCurrent price vs 52-week peak | +45.6% | +64.0% | +63.0% | +79.7% | +95.6% |
| RSI (14)Momentum oscillator 0–100 | 46.3 | 64.8 | 62.9 | 59.6 | 68.8 |
| Avg Volume (50D)Average daily shares traded | 1.5M | 818K | 2.7M | 2.0M | 840K |
Analyst Outlook
XMTR leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: MBOT as "Buy", SSYS as "Buy", DDD as "Hold", XMTR as "Buy". Consensus price targets imply 158.2% upside for MBOT (target: $6) vs -18.1% for XMTR (target: $64).
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Hold | — | Buy |
| Price TargetConsensus 12-month target | $5.50 | $13.50 | $5.00 | — | $64.33 |
| # AnalystsCovering analysts | 3 | 36 | 36 | — | 14 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — | — |
| Dividend StreakConsecutive years of raises | 0 | — | 0 | — | 1 |
| Dividend / ShareAnnual DPS | — | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | 0.0% | +6.4% | +0.2% |
XMTR leads in 2 of 6 categories (Total Returns, Analyst Outlook). DDD leads in 1 (Profitability & Efficiency). 3 tied.
MBOT vs SSYS vs DDD vs NNDM vs XMTR: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is MBOT or SSYS or DDD or NNDM or XMTR a better buy right now?
For growth investors, Nano Dimension Ltd.
(NNDM) is the stronger pick with 77. 3% revenue growth year-over-year, versus -12. 1% for 3D Systems Corporation (DDD). 3D Systems Corporation (DDD) offers the better valuation at 12. 6x trailing P/E, making it the more compelling value choice. Analysts rate Microbot Medical Inc. (MBOT) a "Buy" — based on 3 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — MBOT or SSYS or DDD or NNDM or XMTR?
On forward P/E, Stratasys Ltd.
is actually cheaper at 69. 8x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — MBOT or SSYS or DDD or NNDM or XMTR?
Over the past 5 years, Xometry, Inc.
(XMTR) delivered a total return of -10. 2%, compared to -87. 5% for 3D Systems Corporation (DDD). Over 10 years, the gap is even starker: XMTR returned -10. 2% versus MBOT's -99. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — MBOT or SSYS or DDD or NNDM or XMTR?
By beta (market sensitivity over 5 years), Nano Dimension Ltd.
(NNDM) is the lower-risk stock at 1. 74β versus 3D Systems Corporation's 3. 12β — meaning DDD is approximately 79% more volatile than NNDM relative to the S&P 500. On balance sheet safety, Nano Dimension Ltd. (NNDM) carries a lower debt/equity ratio of 2% versus 126% for Xometry, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — MBOT or SSYS or DDD or NNDM or XMTR?
By revenue growth (latest reported year), Nano Dimension Ltd.
(NNDM) is pulling ahead at 77. 3% versus -12. 1% for 3D Systems Corporation (DDD). On earnings-per-share growth, the picture is similar: 3D Systems Corporation grew EPS 109. 8% year-over-year, compared to -211. 4% for Nano Dimension Ltd.. Over a 3-year CAGR, NNDM leads at 32. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — MBOT or SSYS or DDD or NNDM or XMTR?
3D Systems Corporation (DDD) is the more profitable company, earning 16.
7% net margin versus -98. 0% for Nano Dimension Ltd. — meaning it keeps 16. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MBOT leads at 0. 0% versus -89. 7% for NNDM. At the gross margin level — before operating expenses — SSYS leads at 47. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is MBOT or SSYS or DDD or NNDM or XMTR more undervalued right now?
On forward earnings alone, Stratasys Ltd.
(SSYS) trades at 69. 8x forward P/E versus 185. 0x for Nano Dimension Ltd. — 115. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MBOT: 158. 2% to $5. 50.
08Which pays a better dividend — MBOT or SSYS or DDD or NNDM or XMTR?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is MBOT or SSYS or DDD or NNDM or XMTR better for a retirement portfolio?
For long-horizon retirement investors, Nano Dimension Ltd.
(NNDM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding. 3D Systems Corporation (DDD) carries a higher beta of 3. 12 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (NNDM: -97. 5%, DDD: -81. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between MBOT and SSYS and DDD and NNDM and XMTR?
These companies operate in different sectors (MBOT (Healthcare) and SSYS (Technology) and DDD (Technology) and NNDM (Technology) and XMTR (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: MBOT is a small-cap quality compounder stock; SSYS is a small-cap quality compounder stock; DDD is a small-cap deep-value stock; NNDM is a small-cap high-growth stock; XMTR is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.